What Researchers Did
Researchers conducted a retrospective observational study on 13 patients with acute invasive fungal rhinosinusitis (AIFRS) to characterize their clinical features, microbiology, and treatment outcomes.
What They Found
Out of 13 patients, the overall mortality rate was 53.8%, with 38.5% directly attributed to AIFRS. Four patients underwent orbital exenteration and survived. Notably, three patients received hyperbaric oxygen therapy as an adjunctive treatment, and all three survived with no reported fatalities.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy (HBOT) could be a beneficial additional treatment for Canadian patients suffering from severe acute invasive fungal rhinosinusitis, especially given the high mortality rate associated with this infection. While not a primary treatment, its use alongside standard care might improve survival outcomes for immunocompromised individuals.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study's small sample size of 13 patients and its retrospective observational design limit the generalizability of these findings.